Pfizer reaches multi-year agreement with Gilead to manufacture remdesivir to treat COVID-19

Pfizer Inc announced on Friday that it reached a multi-year agreement with Gilead Sciences to manufacture and supply Gilead's investigational antivira
Leia mais Previous

Canada Participation Rate below forecasts (64.4%) in July: Actual (64.3%)

Canada Participation Rate below forecasts (64.4%) in July: Actual (64.3%)
Leia mais Next